Clinical Trial Update: Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

View source ↗

Summary

This clinical trial update presents measurements of interleukin-6, procalcitonin, and vascular endothelial growth factor in CAPD patients treated with Iplasma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Iplasma

Snippet

Sponsor: Bangkok Metropolitan Administration Medical College and Vajira Hospital | Conditions: Chronic Kidney Disease | Status: COMPLETED